December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Mutation analysis of USH genes in patients with USH and non-syndromic RP
Author Affiliations & Notes
  • XZ Liu
    Otolaryngology University of Miami Miami FL
  • XM Ouyang
    Otolaryngology University of Miami Miami FL
  • JF Hejtmancik
    NEI/NIH Bethesda MD
  • SG Jacobson
    Scheie Eye Institute University of Pennsylvania Philadelphia PA
  • AR Li
    NEI/NIH Bethesda MD
  • LL Du
    Otolaryngology University of Miami Miami FL
  • VE Newton
    Center for Audiology University of Manchester Manchester United Kingdom
  • WE Nance
    Human Genetics Virginia Commonwealth University Richmond VA
  • Footnotes
    Commercial Relationships   X.Z. Liu, None; X.M. Ouyang, None; J.F. Hejtmancik, None; S.G. Jacobson, None; A.R. Li, None; L.L. Du, None; V.E. Newton, None; W.E. Nance, None. Grant Identification: Support: Foundation Fighting Blindness
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2391. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      XZ Liu, XM Ouyang, JF Hejtmancik, SG Jacobson, AR Li, LL Du, VE Newton, WE Nance; Mutation analysis of USH genes in patients with USH and non-syndromic RP . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2391.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Usher syndrome (USH) is defined by the association of visual impairment due to RP and sensorineural deafness. The syndrome can be divided into three subtypes based on the severity and progression of the major clinical findings. These subtypes are genetically heterogeneous, with at least six loci for USH1, three for USH2 and one for USH3. So far, the causative genes have been identified for USH1B, USH1C, USH1D, USH1F, USH2A, and USH3. The aim of this study is to identify novel mutations, to determine the frequency and distribution of mutations, and to investigate the genotype-phenotype correlations at currently recognized genes for USH. Methods: We employed a sequential screening approach to analyze the role of cloned USH genes in a large collection of DNA from patients/families with USH and RP. 230 USH including 128 type 1, 78 type 2, and 24 type 3 (atypical) as well as 93 non-syndromic RP were included in the present study. Segregation analysis was carried out using the flanking markers around 10 USH loci in 42 suitable families. Detection of mutations will be staged by screening for common mutations in the first instance and progressively increasing the range of tests. Amplified fragments for exons of each gene were analysed by combined SSCP/heteroduplex method, and variant bands were sequenced. Results: We have identified a variety of mutations and polymorphisms in MYO7A, USH1C, and USH2A in USH patients and have shown no mutations in MYO7A and CDH23 in RP cases. The RP associated mutation (C759F) in USH2A was detected only in one RP patient. Screening for mutation in CDH23, PCDH15, and USH3 is underway. Conclusion: The recent identification of genes for UHS has opened an avenue to investigate molecular genetic basis of USH. We report the mutation screen results of the newly cloned USH genes. We have identified a number of novel mutations in our patient panels. Identification of novel mutations may provide insight into the phenotypic variation. Moreover, identification of patients/families that do not have mutations in the cloned USH genes would be essential for reducing the impact of heterogeneity on the search for new USH genes.

Keywords: 562 retinal degenerations: hereditary • 480 mutations • 420 genetics 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.